Geneva, Switzerland — India is holding up export licenses for COVID-19 vaccines destined for poor countries due to increased domestic demand as its own cases rise, COVAX Facility co-leader Gavi said Thursday.
The AstraZeneca-Oxford vaccine is being produced under license in India for the COVAX scheme, also led by the World Health Organization (WHO), which is meant to ensure that low-income countries can access COVID-19 jabs.
But shipments planned for the rest of March and April are now being delayed.
“Delays in granting further export licenses for Serum Institute (SII) of India-produced COVID-19 vaccine doses are due to the increased demand of Covid-19 vaccines in India,” a Ga…
Keep on reading: COVAX vaccines for poor countries delayed by India – Gavi